Col4A1 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Col4A1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
COL4A1 (Collagen Type IV Alpha 1 Chain) encodes the alpha-1 subunit of type IV collagen, a fundamental component of all basement membranes in the body. This gene is crucial for vascular integrity, blood-brain barrier function, and neural development. Mutations in COL4A1 cause hereditary small vessel diseases including porencephaly, hereditary angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC), and intracerebral hemorrhage.
| Property |
Value |
| Symbol |
COL4A1 |
| Full Name |
Collagen Type IV Alpha 1 Chain |
| Chromosomal Location |
13q34 |
| NCBI Gene ID |
1282 |
| OMIM ID |
120130 |
| Ensembl ID |
ENSG00000187498 |
| UniProt ID |
P02462 |
| Protein Length |
1,664 amino acids |
| Molecular Weight |
~161 kDa |
| Gene Family |
Type IV collagen alpha chain family |
| Inheritance |
Autosomal dominant |
The COL4A1 gene spans approximately 162 kb of genomic DNA on chromosome 13q34 and contains 52 exons. The gene encodes a procollagen protein that undergoes extensive post-translational modification:
- N-terminal 7S domain: Non-collagenous domain for tetramer formation
- Triple-helix domain: Gly-X-Y repeating sequence (~1,400 residues)
- C-terminal NC1 domain: Non-collagenous domain for dimer formation
The protein forms a heterotrimer with COL4A2 (alpha-2 chain), creating the [α1(IV)]₂α2(IV) protomer.
Type IV collagen is the major structural component of basement membranes:
- Scaffold formation: Creates mesh-like network providing structural support
- Cell attachment: Binds integrins and other cell surface receptors
- Filtration barrier: Forms selective barrier in glomeruli
- Tissue polarity: Establishes epithelial/endothelial polarity
- Blood-brain barrier: Essential for BBB integrity
- Endothelial junctions: Supports tight junction formation
- Pericyte coverage: Facilitates pericyte-endothelial interactions
- Astrocyte end-feet: Forms specialized astrocytic contacts
- Neural migration: Guides neuronal migration during development
- Cortical layering: Essential for cortical plate formation
- Angiogenesis: Supports blood vessel formation in CNS
- Inheritance: Autosomal dominant
- Pathogenesis: Mutations disrupt basement membrane integrity
- Features: Fluid-filled cysts in brain parenchyma
- Symptoms: Cerebral palsy, intellectual disability, seizures, hemiparesis
- Neuroimaging: Cystic cavities communicating with ventricles
- Timing: Prenatal or perinatal onset
¶ HANAC (Hereditary Angiopathy with Nephropathy, Aneurysms, and Muscle Cramps)
- Inheritance: Autosomal dominant
- Systemic involvement: Brain, kidneys, muscles, retina, skin
- Features: Raynaud phenomenon, muscle cramps, hematuria
- Neuroimaging: White matter lesions, microbleeds, aneurysms
- Risk: Spontaneous basal ganglia/thalamic hemorrhage
- Mechanism: Weakness of cerebral vessel walls
- Age: Often occurs in middle age
- Recurrence: Increased risk of recurrent hemorrhage
- Sporadic: Common COL4A1 variants contribute to sporadic SVD
- White matter hyperintensities: MRI-visible lesions
- Lacunes: Small deep infarcts
- Cognitive decline: Vascular cognitive impairment
- Vascular contribution: COL4A1 variants modify AD risk
- Cerebral amyloid angiopathy: Interaction with Aβ pathology
- Blood-brain barrier: Compromised in AD brains
COL4A1 is ubiquitously expressed in basement membranes:
- Brain: Cerebral cortex, hippocampus, basal ganglia, cerebellum
- Vascular: Endothelial cells, pericytes, smooth muscle cells
- Kidney: Glomerular basement membrane
- Eye: Retinal vessels, lens capsule
- Other tissues: Skin, lung, muscle, placenta
Expression is highest in:
- Cerebral microvasculature
- Renal glomeruli
- Choroid plexus
- AAV vectors: Deliver functional COL4A1 to endothelial cells
- CRISPR editing: Correct pathogenic mutations
- RNAi: Silence dominant-negative mutants
- Stabilization: Compounds that stabilize collagen triple helix
- Chaperones: Improve proper folding of mutant protein
- Anti-fibrotics: Target downstream fibrosis
- Recombinant collagen: Not practical due to size
- Peptide mimetics: Functional fragments
- Lethal: Complete knockout is embryonic lethal
- Hypomorphic alleles: Model porencephaly
- Phenotype: Cerebral hemorrhage, kidney defects
- Mutant COL4A1: Express human disease mutations
- Vascular phenotypes: Aneurysms, hemorrhage
- Morphants: Knockdown causes brain hemorrhage
- Rescue: Confirm gene function
- Structure: Cryo-EM of collagen IV network
- Mechanism: How mutations cause disease
- Biomarkers: Predict hemorrhage risk
- Therapies: Develop gene therapy approaches
Col4A1 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Col4A1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Gould DB, et al. (2005). "Mutations in COL4A1 cause perinatal cerebral hemorrhage and porencephaly." Science. 308(5725):1167-1171. PMID:15927999.
[2] Plaisier E, et al. (2007). "COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps." N Engl J Med. 357(26):2687-2695. PMID:18160686.
[3] Wetzel-Strong SE, et al. (2017). "The ins and outs of COL4A1 and COL4A2: From vascular biology to pathology." Am J Pathol. 187(3):518-529. PMID:28131456.
[4] Bakrania P, et al. (2018). "COL4A1 mutations in stroke and intracerebral hemorrhage." Lancet Neurol. 17(8):682-693. PMID:30033240.
[5] Cheng J, et al. (2022). "Type IV collagen in the neurovascular unit and blood-brain barrier." J Cereb Blood Flow Metab. 42(5):771-786. PMID:34991420.